Off-Label Use of Rituximab in Dermatology: Pemphigus Treatment

Anais Brasileiros de Dermatologia - Brazil
doi 10.1590/abd1806-4841.20131905
Full Text
Abstract

Available in full text

Categories
Dermatology
Date
Authors
Publisher

FapUNIFESP (SciELO)

Related search

Available Evidence and Outcome of Off-Label Use of Rituximab in Clinical Practice

European Journal of Clinical Pharmacology
MedicinePharmacology
2013English

Off-Label Use of Rituximab in Refractory Pediatric Rheumatic Diseases: A Single-Center Experience

Pediatric Rheumatology
ImmunologyPediatricsRheumatologyAllergyPerinatologyChild Health
2014English

Systemic Lupus Erythematosus: Extent and Patterns of Off-Label Use of Rituximab for SLE

Nature Reviews Rheumatology
Rheumatology
2016English

«Off Label Use»: Nouvelles Recommandations

Bulletin des Médecins Suisses
2007English

Off-Label Use of Approved Drugs

Nature Reviews Clinical Oncology
Oncology
2009English

Off-Label Drug Use in Hospitalized Children

Archives of Pediatrics & Adolescent Medicine
2007English

Off-Label Use of Omalizumab in Pediatric Anaphylaxis

Journal of Allergy and Clinical Immunology
AllergyImmunology
2019English

Methylphenidate Off-Label Use and Safety

SpringerPlus
Multidisciplinary
2014English

Off-Label Use in Lymphoma Patients in Switzerland

Hematological Oncology
MedicineCancer ResearchOncologyHematology
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2026 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy